Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Long-Term Investments: 2021-2025

Historic Long-Term Investments for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $302.9 million.

  • Roivant Sciences' Long-Term Investments rose 32.43% to $412.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $412.3 million, marking a year-over-year increase of 32.43%. This contributed to the annual value of $302.9 million for FY2025, which is 22.27% up from last year.
  • Latest data reveals that Roivant Sciences reported Long-Term Investments of $302.9 million as of FY2025, which was up 4.45% from $290.0 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Long-Term Investments ranged from a high of $398.7 million in FY2021 and a low of $189.0 million during FY2021.
  • In the last 3 years, Roivant Sciences' Long-Term Investments had a median value of $290.0 million in 2024 and averaged $277.0 million.
  • The largest annual percentage gain for Roivant Sciences' Long-Term Investments in the last 5 years was 72.42% (2022), contrasted with its biggest fall of 31.67% (2022).
  • Roivant Sciences' Long-Term Investments (Yearly) stood at $189.0 million in 2021, then reached $398.7 million in 2021, then skyrocketed by 72.42% to $325.8 million in 2022, then tumbled by 31.67% to $272.5 million in 2022, then fell by 6.60% to $304.3 million in 2023, then dropped by 11.94% to $239.9 million in 2023, then decreased by 18.59% to $247.8 million in 2024, then rose by 20.89% to $290.0 million in 2024, then rose by 22.27% to $302.9 million in 2025.